Printer Friendly

'HALFPRIN' NEW LOW STRENGTH ADULT ASPIRIN INTRODUCED BY KRAMER LABORATORIES

 'HALFPRIN' NEW LOW STRENGTH ADULT ASPIRIN
 INTRODUCED BY KRAMER LABORATORIES
 MIAMI, Feb. 3 /PRNewswire/ -- Halfprin, a new adult low-strength (165 mg.) enteric coated aspirin tablet has been introduced by Kramer Laboratories for men and women who use aspirin regularly to protect their health.
 Kramer says the new tablet helps patients follow their doctors' orders because Halfprin's low strength makes it easier to take different doses. There is usually no need to break tablets or alternate the daily dose to get the exact amount of aspirin prescribed by physicians.
 An additional advantage is Halfprin's enteric coating, which helps reduce the chance of stomach irritation. This can be a problem when aspirin is taken on a continuing basis.
 Recent studies have shown regular doses of aspirin to be effective in reducing the risk of heart disease, colon and rectal cancer.
 Halfprin is available at all local pharmacies. It is sold in packages of 60 tablets and bottles of 200.
 -0- 2/3/92
 /CONTACT: Dan Greenberg of Dan Greenberg Associates, 305-662-2011, for Kramer Laboratories/ CO: Kramer Laboratories ST: Florida IN: MTC SU: PDT


SS-AW-AK -- FL001 -- 6016 02/03/92 09:11 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 3, 1992
Words:190
Previous Article:FIRST SECURE COMPUTER FAX INTERFACE WILL BE DEMONSTRATED THIS WEEK AT MILITARY TRADE SHOW IN WASHINGTON
Next Article:PHARMAKINETICS LABORATORIES CHANGE IN CERTIFYING ACCOUNTANTS
Topics:


Related Articles
WHITEHALL LABORATORIES REAFFIRMS ITS COMMITMENT TO CHILD RESISTANT CLOSURES
The same ingredients in many disguises.
St. Joseph 81mg Aspirin Returns, This Time for Baby Boomers.
New Research Reinforces Aspirin's Role in Heart Health; - Leading Cardiologist Urges Americans to Talk With Their Doctor -.
Kramer Laboratories Meets Demand ... Just In Time Through A Strategic Alliance With 3PF.
New Study Supports Low Dose Aspirin as Safer Alternative for Daily Heart Therapy; - Higher Doses of Aspirin Linked With Increased Risk of Bleeding -.
New Data Presented at European Society of Cardiology Congress 2005 Reinforces Relative Safety of Low-Dose Aspirin Over Higher Doses.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters